A blood test that could spot kidney trouble in diabetes?

NCT ID NCT07773467

NEW Not yet recruiting Diagnosis Sponsor: Assiut University Source: ClinicalTrials.gov ↗

First seen Aug 19, 2026 · Last updated Aug 19, 2026

Summary

This study looks at whether routine blood test markers—like the Systemic Immune-Inflammation Index and platelet ratios—can help identify diabetic kidney disease in people with type 2 diabetes. Researchers will compare these markers across patients with different levels of albuminuria (a sign of kidney damage) and healthy controls. The goal is to find a simple, cost-effective way to detect and track this common complication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: No drug or intervention is being tested. This observational study analyzes routine blood test markers (Systemic Immune-Inflammation Index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and platelet indices) as potential biomarkers.
What this could lead to: If these blood markers prove reliable, they could offer a simple, low-cost way to detect diabetic kidney disease earlier and monitor its progression.
What could go wrong: This is an observational study, so it can't prove cause and effect. The markers may not be specific enough to distinguish diabetic kidney disease from other conditions, and results may not generalize beyond this patient group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALBUMINURIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Albuminuria diabetic kidney disease proteinuria type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALBUMINURIA DIABETIC KIDNEY DISEASE DIABETIC NEPHROPATHIES TYPE 2 DIABETES MELLITUS

More trials for these conditions

Other studies related to the condition(s) this trial covers.